Press "Enter" to skip to content

New patent for Theratechnologies drug EGRIFTA

0
Copyright © DrugPatentWatch. Originally published at New patent for Theratechnologies drug EGRIFTA

Annual Drug Patent Expirations for EGRIFTA
Annual Drug Patent Expirations for EGRIFTA

Egrifta is a drug marketed by Theratechnologies and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

This drug has forty-two patent family members in sixteen countries.

The generic ingredient in EGRIFTA is tesamorelin acetate. One supplier is listed for this compound. Additional details are available on the tesamorelin acetate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Theratechnologies drug EGRIFTA
    Do NOT follow this link or you will be banned from the site!